SCHEMBL23595253

SCHEMBL23595253

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4cccc(-n5c6ccccc6c6c7c(ccc65)oc5ccccc57)c4)cc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.35
PLA2G4A P47712 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
KDM4E B2RXH2 2/20 0.34
ATM Q13315 1/20 0.34
PLA2G10 O15496 1/20 0.34
HPSE Q9Y251 2/20 0.33
PGR P06401 1/20 0.33
GAA P10253 1/20 0.33
PDE10A Q9Y233 1/20 0.32
TSHR P16473 2/20 0.32
LMNA P02545 2/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
HSD17B10 Q99714 1/20 0.32
WNK1 Q9H4A3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24217367 0.99 KDM4E (0.35) PLA2G2APLA2G4AL3MBTL1KDM4EATM
SCHEMBL24217366 0.98 KDM4E (0.34) PLA2G2APLA2G4AL3MBTL1KDM4EATM
SCHEMBL23595226 0.97 KDM4E (0.35) PLA2G2APLA2G4AL3MBTL1KDM4EATM
SCHEMBL24217365 0.97 KDM4E (0.36) L3MBTL1KDM4EATMTSHRLMNA
SCHEMBL23595254 0.96 PLA2G2A (0.33) PLA2G2APLA2G4AL3MBTL1KDM4EATM
SCHEMBL16811394 0.94 CHEK2 (0.36) PLA2G2APLA2G4AL3MBTL1KDM4EATM
SCHEMBL25133041 0.94 PLA2G2A (0.36) PLA2G2APLA2G4AL3MBTL1KDM4EATM
SCHEMBL22192778 0.94 KDM4E (0.38) L3MBTL1KDM4EATMTSHRLMNA
SCHEMBL22192605 0.94 KDM4E (0.38) L3MBTL1KDM4EATMTSHRLMNA
SCHEMBL18564569 0.94 L3MBTL1 (0.35) L3MBTL1KDM4EATMTSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230099759-A1 POLYCYCLIC COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2023-03-30 US disclosed
WO-2021132733-A1 POLYCYCLIC COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2021-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230099759-A1 POLYCYCLIC COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND SLCO4C1, SLCO1A2, PORCN PLA2G2A 4069/4885PLA2G4A 4733/4885L3MBTL1 3007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.